Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Illumina Inc
(NQ:
ILMN
)
140.78
+3.79 (+2.77%)
Streaming Delayed Price
Updated: 2:06 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Illumina Inc
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
January 18, 2024
With the value of the cancer testing market expected to soar over the next decade, here are the three best disease testing stocks to buy now.
Via
InvestorPlace
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
Via
Benzinga
Biotech Playbook: Small Caps Show Momentum Peaking During
January 15, 2024
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.
Via
Talk Markets
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 09, 2024
Shares of JetBlue Airways Corporation (NASDAQ: JBLU) fell sharply during Tuesday’s session.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
Via
Benzinga
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit
January 09, 2024
Illumina, Inc. (NASDAQ: ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and
Via
Benzinga
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
January 09, 2024
U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Illumina Inc. (NASDAQ: ILMN) Highlighted for Surprising Price Action
January 09, 2024
Via
Investor Brand Network
Why Illumina Rallied 36.6% in December
January 09, 2024
The beaten-down gene sequencing company is getting a further shakeup.
Via
The Motley Fool
Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings)
January 04, 2024
Via
Benzinga
ILMN DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
January 08, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc. (ILMN)
January 08, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ILMN DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
January 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ILLUMINA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
January 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ILMN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN
January 05, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit
January 05, 2024
Illumina, Inc. (NASDAQ: ILMN) announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson (NYSE: JNJ).
Via
Benzinga
ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
January 05, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm
January 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
December 31, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
December 29, 2023
WHY: NEW YORK, NY - (NewMediaWire) - December 29, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023 and...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm
December 28, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action – ILMN
December 28, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options
December 27, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Small Caps Are On A Tear Including Speculative Biotechs
December 26, 2023
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.
Via
Talk Markets
ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN
December 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm
December 24, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – ILMN
December 24, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN
December 23, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Stock Market Rally Is In Merry Mood Heading Into Christmas Weekend: Weekly Review
December 22, 2023
Despite a Wednesday tumble, the major indexes are right at 2023 highs.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.